DK1341766T3 - Imidazolonderivater til behandling af virussygdomme - Google Patents
Imidazolonderivater til behandling af virussygdommeInfo
- Publication number
- DK1341766T3 DK1341766T3 DK01997479T DK01997479T DK1341766T3 DK 1341766 T3 DK1341766 T3 DK 1341766T3 DK 01997479 T DK01997479 T DK 01997479T DK 01997479 T DK01997479 T DK 01997479T DK 1341766 T3 DK1341766 T3 DK 1341766T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- viral diseases
- imidazolone derivatives
- imidazolone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028484.4A GB0028484D0 (en) | 2000-11-22 | 2000-11-22 | Imidazolone derivatives for the treatment of viral diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1341766T3 true DK1341766T3 (da) | 2006-02-20 |
Family
ID=9903671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01997479T DK1341766T3 (da) | 2000-11-22 | 2001-11-12 | Imidazolonderivater til behandling af virussygdomme |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6518293B2 (es) |
| EP (1) | EP1341766B1 (es) |
| JP (1) | JP2004514672A (es) |
| KR (1) | KR100528760B1 (es) |
| CN (1) | CN1633417A (es) |
| AR (1) | AR035372A1 (es) |
| AT (1) | ATE307805T1 (es) |
| AU (2) | AU2184202A (es) |
| BR (1) | BR0115476A (es) |
| CA (1) | CA2428461A1 (es) |
| DE (1) | DE60114448T2 (es) |
| DK (1) | DK1341766T3 (es) |
| ES (1) | ES2251529T3 (es) |
| GB (1) | GB0028484D0 (es) |
| MX (1) | MXPA03004454A (es) |
| PA (1) | PA8533301A1 (es) |
| PE (1) | PE20020636A1 (es) |
| UY (1) | UY27035A1 (es) |
| WO (1) | WO2002042279A1 (es) |
| ZA (1) | ZA200303690B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200423930A (en) * | 2003-02-18 | 2004-11-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitors |
| EP1740550A1 (en) * | 2004-04-14 | 2007-01-10 | Pfizer Limited | Sulphur-linked imidazole compounds for the treament of hiv |
| CA2592909A1 (en) * | 2005-01-06 | 2006-07-13 | Pfizer Limited | Imidazole derivatives as enzyme reverse transcriptase modulators |
| WO2008085008A1 (en) * | 2007-01-11 | 2008-07-17 | Mogam Biotechnology Research Institute | T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| KR101110120B1 (ko) * | 2009-10-28 | 2012-01-31 | 주식회사 케이아이테크놀로지 | 표지판 완충장치 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4345936A (en) * | 1981-10-05 | 1982-08-24 | Eli Lilly And Company | Imidazoles, compositions and herbicidal method |
| TW235963B (es) | 1992-01-16 | 1994-12-11 | Shionogi & Co | |
| WO1993015060A1 (en) | 1992-01-22 | 1993-08-05 | Nissan Chemical Industries, Ltd. | Substituted pyrazole derivative and agrohorticultural bactericide |
| GB9222262D0 (en) | 1992-10-23 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
| US5612636A (en) * | 1995-01-19 | 1997-03-18 | Texas Instruments Incorporated | Short circuit power optimization for CMOS circuits |
| US5612363A (en) | 1995-06-02 | 1997-03-18 | Berlex Laboratories, Inc. | N,N-di(aryl) cyclic urea derivatives as anti-coagulants |
| US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
-
2000
- 2000-11-22 GB GBGB0028484.4A patent/GB0028484D0/en not_active Ceased
-
2001
- 2001-11-06 US US09/993,848 patent/US6518293B2/en not_active Expired - Fee Related
- 2001-11-12 CA CA002428461A patent/CA2428461A1/en not_active Abandoned
- 2001-11-12 AU AU2184202A patent/AU2184202A/xx active Pending
- 2001-11-12 CN CNA018193528A patent/CN1633417A/zh active Pending
- 2001-11-12 ES ES01997479T patent/ES2251529T3/es not_active Expired - Lifetime
- 2001-11-12 WO PCT/EP2001/013069 patent/WO2002042279A1/en active IP Right Grant
- 2001-11-12 AU AU2002221842A patent/AU2002221842B2/en not_active Ceased
- 2001-11-12 AT AT01997479T patent/ATE307805T1/de not_active IP Right Cessation
- 2001-11-12 BR BR0115476-1A patent/BR0115476A/pt not_active IP Right Cessation
- 2001-11-12 MX MXPA03004454A patent/MXPA03004454A/es active IP Right Grant
- 2001-11-12 DK DK01997479T patent/DK1341766T3/da active
- 2001-11-12 JP JP2002544414A patent/JP2004514672A/ja active Pending
- 2001-11-12 KR KR10-2003-7006881A patent/KR100528760B1/ko not_active IP Right Cessation
- 2001-11-12 EP EP01997479A patent/EP1341766B1/en not_active Expired - Lifetime
- 2001-11-12 DE DE60114448T patent/DE60114448T2/de not_active Expired - Fee Related
- 2001-11-20 PE PE2001001158A patent/PE20020636A1/es not_active Application Discontinuation
- 2001-11-21 UY UY27035A patent/UY27035A1/es not_active Application Discontinuation
- 2001-11-21 PA PA20018533301A patent/PA8533301A1/es unknown
- 2001-11-21 AR ARP010105422A patent/AR035372A1/es not_active Application Discontinuation
-
2003
- 2003-05-13 ZA ZA200303690A patent/ZA200303690B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1633417A (zh) | 2005-06-29 |
| MXPA03004454A (es) | 2003-08-19 |
| EP1341766A1 (en) | 2003-09-10 |
| AU2002221842B2 (en) | 2007-08-23 |
| US20020107272A1 (en) | 2002-08-08 |
| KR100528760B1 (ko) | 2005-11-15 |
| BR0115476A (pt) | 2003-08-19 |
| ZA200303690B (en) | 2004-08-13 |
| GB0028484D0 (en) | 2001-01-10 |
| DE60114448D1 (de) | 2005-12-01 |
| KR20030060951A (ko) | 2003-07-16 |
| ES2251529T3 (es) | 2006-05-01 |
| ATE307805T1 (de) | 2005-11-15 |
| CA2428461A1 (en) | 2002-05-30 |
| JP2004514672A (ja) | 2004-05-20 |
| EP1341766B1 (en) | 2005-10-26 |
| AR035372A1 (es) | 2004-05-12 |
| US6518293B2 (en) | 2003-02-11 |
| AU2184202A (en) | 2002-06-03 |
| PE20020636A1 (es) | 2002-07-18 |
| UY27035A1 (es) | 2002-06-20 |
| PA8533301A1 (es) | 2002-08-26 |
| DE60114448T2 (de) | 2006-07-06 |
| WO2002042279A1 (en) | 2002-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
| DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
| DK1762567T3 (da) | Pyrazolderivater til behandling af HIV | |
| DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
| NO20031615D0 (no) | Pyrazol-derivater for behandling av virus-sykdommer | |
| DK1292594T3 (da) | Quinazolinderivater til behandling af tumorer | |
| NO20031442L (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
| DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
| DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| DK1282616T3 (da) | Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter | |
| DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
| DK1456229T3 (da) | Fremgangsmåe til fremstilling af echinocandin-derivater | |
| DK1468996T3 (da) | Indolderivater til behandling af CNS-sygdomme | |
| DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| DK1341766T3 (da) | Imidazolonderivater til behandling af virussygdomme | |
| DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
| NO20032769L (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
| DK1282599T3 (da) | Disulfidderivater, der er egnede til behandling af allergiske sygdomme | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| DK1294694T3 (da) | Fremgangsmåde til fremstilling af quinolinderivater | |
| DK1468686T3 (da) | S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser | |
| NO20033290D0 (no) | Pyrrolderivater for behandling av cytokinformidlede sykdommer |